Earth Science Tech Inc. (ETST) Seeing Revenue Grow
Post# of 281
(Total Views: 152)
Posted On: 10/11/2019 6:35:44 PM
Earth Science Tech Inc. (ETST) Seeing Revenue Growth, Focusing on Supplying High Quality Hemp Oil
- Earth Science Tech focuses on researching and developing inventive hemp extracts
- The company has three unique, wholly owned subsidiaries
- ETST recently reported a significant increase in revenue and gross profit
A science-based biotech company, Earth Science Tech Inc. (OTCQB: ETST) operates in the hemp-derived cannabinoids, nutraceuticals, pharmaceuticals, medical-devices, and research and development (R&D) fields. The company focuses on researching and developing unique hemp extracts and making those extracts accessible globally. The company offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market.
Recently, Earth Science Tech reported a 36 percent revenue gain as well as a 90 percent increase in gross profit for the quarter ended June 30, 2019 (http://cnw.fm/boI2I). Full-spectrum cannabinoids are propelling the company’s consistent sales. Of note for investors is that Earth Science Tech earlier reported product sales totaled $770,635 for fiscal year ending March 31, 2019. This represents a 66.4 percent increase as compared to the $463,108 recorded for the same period in 2018. At the same time, the company maintained an impressive gross profit total of $295,013 and a gross margin of 38.2 percent in 2019.
The company’s significant revenue success is due in no small part to its diverse array of subsidiaries. Headquartered in Doral, Florida, Earth Science Tech has three wholly owned subsidiaries: Earth Science Pharmaceutical Inc., Cannabis Therapeutics Inc., and Canadian subsidiary Canna Inno Laboratories Inc.
Earth Science Pharmaceutical concentrates on becoming an international leader in the development of low-cost, non-invasive diagnostic tools, medical devices, testing processes, and vaccines for STIs (sexually transmitted infections and/or diseases). The company is dedicated to developing pioneering medical devices and vaccines that will improve health worldwide, particularly for women. ETST’s first medical device is MSN-2, a home kit designed for the detection of STIs from a self-obtained gynecological specimen.
Earth Science Tech’s Cannabis Therapeutics subsidiary is an emerging biotech company invested in research and development to explore and harness the medicinal power of cannabidiol. Cannabis Therapeutics is positioned to become a world leader in cannabinoid R&D for a wide-ranging line of cannabinoid-based pharmaceuticals, nutraceuticals and other product solutions. The company’s initial projects are focused on developing treatments for breast and ovarian cancers.
The Canna Inno Laboratories subsidiary, a strategic Montreal-based company, is giving Earth Science Tech a foothold in Quebec. Canna Inno allows ETST access to Government of Canada funding, the first of which has recently been approved. This subsidiary will also enable the advancement of further product via grants offered to pharmaceutical innovators (http://cnw.fm/3cWrD).
Earth Science Tech’s high-grade, CBD-rich hemp oil is formulated using a broad array of innovative technologies. The process includes a super-critical extraction process (CO2), isolation and micron filtration. Super-critical extraction is a gentle approach and is the key method in the extraction of the company’s CBD (http://cnw.fm/p0n5X).
Earth Science Tech markets a complete line of high-grade, hemp-CBD oils, hemp-CBD caps, and CBD pet oil products with its full-spectrum and pure CBD oils. The company’s CBD-rich hemp oil contains no synthetic cannabinoids and is not an isolate. Rather, the oil contains everything that is naturally occurring in the original industrial hemp plant. The company’s commercialized CBD-based product line, High Grade Full Spectrum Cannabinoids, provides seven distinct cannabinoids, and is formulated to maximize all the therapeutic benefits the industrial-hemp plant has to offer.
With a management team consisting of industry experts with decades of experience in the nutraceuticals, dietary-supplements and life-sciences fields, Earth Science Tech continues to innovate in the CBD space. The company offers investors a strong platform and exposure to multiple markets experiencing rapid growth. ETST is consistently executing on its strategic mission to expand its role as a leader in diverse market sectors.
For more information, visit the company’s website at www.EarthScienceTech.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Earth Science Tech focuses on researching and developing inventive hemp extracts
- The company has three unique, wholly owned subsidiaries
- ETST recently reported a significant increase in revenue and gross profit
A science-based biotech company, Earth Science Tech Inc. (OTCQB: ETST) operates in the hemp-derived cannabinoids, nutraceuticals, pharmaceuticals, medical-devices, and research and development (R&D) fields. The company focuses on researching and developing unique hemp extracts and making those extracts accessible globally. The company offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market.
Recently, Earth Science Tech reported a 36 percent revenue gain as well as a 90 percent increase in gross profit for the quarter ended June 30, 2019 (http://cnw.fm/boI2I). Full-spectrum cannabinoids are propelling the company’s consistent sales. Of note for investors is that Earth Science Tech earlier reported product sales totaled $770,635 for fiscal year ending March 31, 2019. This represents a 66.4 percent increase as compared to the $463,108 recorded for the same period in 2018. At the same time, the company maintained an impressive gross profit total of $295,013 and a gross margin of 38.2 percent in 2019.
The company’s significant revenue success is due in no small part to its diverse array of subsidiaries. Headquartered in Doral, Florida, Earth Science Tech has three wholly owned subsidiaries: Earth Science Pharmaceutical Inc., Cannabis Therapeutics Inc., and Canadian subsidiary Canna Inno Laboratories Inc.
Earth Science Pharmaceutical concentrates on becoming an international leader in the development of low-cost, non-invasive diagnostic tools, medical devices, testing processes, and vaccines for STIs (sexually transmitted infections and/or diseases). The company is dedicated to developing pioneering medical devices and vaccines that will improve health worldwide, particularly for women. ETST’s first medical device is MSN-2, a home kit designed for the detection of STIs from a self-obtained gynecological specimen.
Earth Science Tech’s Cannabis Therapeutics subsidiary is an emerging biotech company invested in research and development to explore and harness the medicinal power of cannabidiol. Cannabis Therapeutics is positioned to become a world leader in cannabinoid R&D for a wide-ranging line of cannabinoid-based pharmaceuticals, nutraceuticals and other product solutions. The company’s initial projects are focused on developing treatments for breast and ovarian cancers.
The Canna Inno Laboratories subsidiary, a strategic Montreal-based company, is giving Earth Science Tech a foothold in Quebec. Canna Inno allows ETST access to Government of Canada funding, the first of which has recently been approved. This subsidiary will also enable the advancement of further product via grants offered to pharmaceutical innovators (http://cnw.fm/3cWrD).
Earth Science Tech’s high-grade, CBD-rich hemp oil is formulated using a broad array of innovative technologies. The process includes a super-critical extraction process (CO2), isolation and micron filtration. Super-critical extraction is a gentle approach and is the key method in the extraction of the company’s CBD (http://cnw.fm/p0n5X).
Earth Science Tech markets a complete line of high-grade, hemp-CBD oils, hemp-CBD caps, and CBD pet oil products with its full-spectrum and pure CBD oils. The company’s CBD-rich hemp oil contains no synthetic cannabinoids and is not an isolate. Rather, the oil contains everything that is naturally occurring in the original industrial hemp plant. The company’s commercialized CBD-based product line, High Grade Full Spectrum Cannabinoids, provides seven distinct cannabinoids, and is formulated to maximize all the therapeutic benefits the industrial-hemp plant has to offer.
With a management team consisting of industry experts with decades of experience in the nutraceuticals, dietary-supplements and life-sciences fields, Earth Science Tech continues to innovate in the CBD space. The company offers investors a strong platform and exposure to multiple markets experiencing rapid growth. ETST is consistently executing on its strategic mission to expand its role as a leader in diverse market sectors.
For more information, visit the company’s website at www.EarthScienceTech.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)